PEDT-02 Clinical usage of NCC Oncopanel/FoundationOne CDx for pediatric/AYA patients with recurrent malignant brain tumors

Backgrounds: Analyses of somatic mutations in malignant brain tumors have been used to make effective treatment strategies. NCC Oncopanel and FoundationOne CDx are custom targeted next-generation sequencing (NGS) panels. The cost for this analysis is 560,000 yen covered by National Health Insurance...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibahara, Ichiyo, Kumabe, Toshihiro, Hide, Takuichiro, Sasao, Ryota, Sasaki, Hikaru, Sasaki, Jiichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699081/
http://dx.doi.org/10.1093/noajnl/vdaa143.037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699081/
http://dx.doi.org/10.1093/noajnl/vdaa143.037

Ejemplares similares